Skip to content

A clinical trial of a new pharyngeal exposure device for pharyngeal swab operation and its effect of testing novel coronavirus pneumonia (COVID-19) infection

A clinical trial of a new pharyngeal exposure device for pharyngeal swab operation and its effect

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000039593
Enrollment
Unknown
Registered
2020-11-02
Start date
2020-03-11
Completion date
Unknown
Last updated
2021-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Gold Standard:Patients who got at least one positive result for the nucleic acid tests for SARS-Cov-2 within a week before the recruitment in Wuhan Union Hospital.
Index test:Diagnostic&#32
of&#32
the&#32
RT-PCR&#32
and&#32
in&#32
pharyngeal&#32
swabbing.

Sponsors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
31 Years to 79 Years

Inclusion criteria

Inclusion criteria: 1. Confirmed COVID-19 patients; 2. Patients aged 18 to 80 years.

Exclusion criteria

Exclusion criteria: 1. Patients unable to understand and cooperate with the trial; 2. Patients with maxillofacial basic disease or deformity; the maximal hight of mouth opening less than 3 fingers; 3. Patients with missing anterior dentition or unable to hold the oris distractor; 4. Patients or their authorizers are unwilling to sign the informed consent or to comply with the study protocol 5. Severe coronavirus pneumonia patients.

Design outcomes

Primary

MeasureTime frame
RT-PCR test for nucleic acid of SARS-CoV-2;

Countries

China

Contacts

Public ContactJia Jie

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

jjwhunion@163.com+86 13507141952

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026